gopubmed logo
 
find other proteinsAll proteins
GoPubMed Proteins lists recent and important papers and reviews for proteins. Page last changed on 28 Aug 2015.

Keratin 19

cytokeratin 19, CK19, K19, keratin 19
The protein encoded by this gene is a member of the keratin family. The keratins are intermediate filament proteins responsible for the structural integrity of epithelial cells and are subdivided into cytokeratins and hair keratins. The type I cytokeratins consist of acidic proteins which are arranged in pairs of heterotypic keratin chains. Unlike its related family members, this smallest known acidic cytokeratin is not paired with a basic cytokeratin in epithelial cells. It is specifically expressed in the periderm, the transiently superficial layer that envelopes the developing epidermis. The type I cytokeratins are clustered in a region of chromosome 17q12-q21. [provided by RefSeq, Jul 2008] (from NCBI)
Top mentioned proteins: cytokeratin, CAN, HAD, CK7, vimentin
Papers using cytokeratin 19 antibodies
Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease.
Supplier
Kodavanti Urmila P. et al., In Environmental Health Perspectives, 2010
... and cytokeratin 14 (sc-53253) using antibodies from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and cytokeratin 19 (CRC946) from Cell Marque (Rocklin, CA, USA).
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Supplier
Richardson Andrea L et al., In Breast Cancer Research : BCR, 2008
antibody, BD Biosciences, San Jose, CA, USA), CK18 (DC10 antibody, Dako) and CK19 (RCK108 antibody, Dako) as well as for ...
The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells
Supplier
Michalopoulos George K et al., In Comparative Hepatology, 2006
... Primary antibodies used are: CK19 (Dako Corp; 1:100), HNF4α (Santa ...
P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing Axin from β-catenin
Supplier
Oshima Masanobu et al., In The EMBO Journal, 2005
... K19-C2mE transgenic mice has been described ...
Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer
Supplier
Schultze Frank C. et al., In Histochemistry and Cell Biology, 2004
... Anti-CK-19 mouse monoclonalIHC1:50Leica Biosys ...
more suppliers
Papers on cytokeratin 19
Adenoid ameloblastoma: clinicopathologic description of five cases and systematic review of the current knowledge.
New
Gomez et al., Uberlândia, Brazil. In Oral Surg Oral Med Oral Pathol Oral Radiol, 30 Sep 2015
Immunohistochemically, the tumors stained focally positive for CK7, 8, 14, and 18 and diffusely positive for CK-19, p16, and p53.
Immunohistochemical characterization of the regenerative compartment in biliary atresia: a comparison between Kasai procedure and transplant cases.
New
Yeh et al., Kao-hsiung, Taiwan. In Hum Pathol, 15 Aug 2015
Immunohistochemistry for CD56, CK7, and CK19 was performed.
Cutaneous metastases from gastric adenocarcinoma 15 years after curative gastrectomy.
New
Sang et al., Nanjing, China. In An Bras Dermatol, Jun 2015
They were stained positive for villin, CDX-2, CKpan (AE1/ AE3), CEA, CK8/18, CK19, CK7, EMA, Ki-67 (50%), and negative for S-100, CK20, CD34, GCDFP-15 and TTF-1.
Diagnostic accuracy of cytokeratin-19 fragment (CYFRA 21-1) for bladder cancer: a systematic review and meta-analysis.
Review
New
Deng et al., Shanghai, China. In Tumour Biol, May 2015
Previous studies have evaluated the accuracy of serum and urinary measurements of cytokeratin-19 fragment (CYFRA 21-1) for the diagnosis of bladder cancer; however, the results have been inconsistent.
Quantitative assessment of the cell surface proteome to identify novel therapeutic targets in cholangiocarcinoma.
New
Impact
Afford et al., Birmingham, United Kingdom. In Lancet, Mar 2015
They included proteins used clinically for staging disease (cytokeratin 19 [CK19]), identifying cancer stem cells (epithelial cell adhesion molecule [EpCAM], neural cell adhesion molecule [NCAM], epithelial growth factor receptor [EGFR]), and indicating potential for differentiation (Frozzled receptor, Notch pathway).
Randomized phase II study of carboplatin and paclitaxel with either linifanib or placebo for advanced nonsquamous non-small-cell lung cancer.
New
Impact
Gorbunova et al., Atlanta, United States. In J Clin Oncol, Mar 2015
Baseline plasma carcinoembryonic antigen/cytokeratin 19 fragments biomarker signature was associated with PFS improvement and a trend toward OS improvement with linifanib 12.5 mg.
Biological and genetic markers in occupational asthma.
Review
New
Park et al., Seoul, South Korea. In Curr Allergy Asthma Rep, Jan 2015
For OA induced by low-molecular-weight agents, such as isocyanate, potential biomarkers include serum-specific IgE and IgG antibodies to isocyanate-HSA conjugate and IgG to cytokeratin 19 and transglutaminase-2.
A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients.
New
Alonso et al., La Plata, Argentina. In Springerplus, Dec 2014
Secondary endpoints included surgical bleeding, plasma levels of vWF, and circulating tumor cells (CTCs) as measured by quantitative PCR of cytokeratin-19 transcripts.
Pathology: Classification and Immunoprofile.
New
Perren et al., Bern, Switzerland. In Front Horm Res, Dec 2014
Many immunohistochemical markers have been shown to correlate with prognosis but are not used in clinical practice, for example cytokeratin 19 and KIT expression in pancreatic NETs.
Usefulness, methods and rationale of lymph nodes HPV-DNA investigation in estimating risk of early stage cervical cancer recurrence: a systematic literature review.
Review
New
Gizzo et al., Padova, Italy. In Clin Exp Metastasis, Oct 2014
The use of ISH test for HPV-DNA detection in LNs, particularly if associated to CK19-assay, improve the accuracy of micro-metastasis detection, and the identification of patients with negative histology but potentially at high-risk of recurrence and poor oncological prognosis.
Usage patterns of biomarkers in non-small-cell lung cancer patients in India: Findings from a systematic review and survey.
Review
New
Mishra et al., Ahmadābād, India. In Lung India, Jul 2014
Significantly elevated levels of CK-18 were observed in patients with squamous cell carcinoma and of CK-19 in patients with adenocarcinoma, squamous cell carcinoma, and NSCLC (P < 0.001).
Nasopharyngeal adenoid cystic carcinoma: a case report and review of the literature.
Review
Xu et al., Dongguan, China. In Int J Clin Exp Pathol, 2013
Histopathological findings showed that tumor cells were arranged in cord-like or acinar-like by atypical hyperplastic epithelial cells forming a cribriform and tubular pattern, and immunohistochemical findings showed that tumor tissues were immunopositive for p63 (+), CK7 (+), CK19 (+), CK8 (+), CK18 (+), SMA (+), CK (+), p53 (++), S-100 (+) and Ki-67 (5%+), and negative for CD34 (-), CK5/6 (-), CEA (-) and CD117 (-).
Structural and functional evaluation of branched myofibers lacking intermediate filaments.
GeneRIF
Lovering et al., Baltimore, United States. In Am J Physiol Cell Physiol, 2012
Branched desmin-deficient (DKO) myofibers show significantly faster rates of calcium ion (Ca2+) clearance, with milder branching phenotype observed in DKO muscle suggesting that absence of keratin-19 corrects the defect created by absence of desmin alone.
Expression of basal cell keratin 15 and keratin 19 in oral squamous neoplasms represents diverse pathophysiologies.
GeneRIF
Yamaguchi et al., Tokyo, Japan. In Histol Histopathol, 2012
K19 expressed variably in both oral squamous cell carcinoma and squamous intraepithelial neoplasm
Importance of assessing CK19 immunostaining in core biopsies in patients subjected to sentinel node study by OSNA.
GeneRIF
Matias-Guiu et al., Lleida, Spain. In Virchows Arch, 2012
lack of expression of CK19 is infrequent in breast cancers, they do occur not only in tumors with a triplenegative or basal-like phenotype but also in breast cancers with a luminal phenotype
Expression of cytokeratin 19, HBME-1 and galectin-3 in neoplastic and nonneoplastic thyroid lesions.
GeneRIF
Kabukçuoglu et al., Turkey. In Pol J Pathol, 2012
105 cases of thyroid lesions were evaluated to assess the role of HBME-1, cytokeratin-19 (CK-19), galectin-3 in distinguishing benign from malignant thyroid lesions.
Usefulness of cytokeratin-19, galectin-3, and Hector Battifora mesothelial-1 in the diagnosis of benign and malignant thyroid nodules.
GeneRIF
Zhang et al., China. In Clin Lab, 2011
combined use of CK19, Gal-3, and HBME-1 is of practical value in the diagnosis and differential diagnosis of benign and malignant thyroid nodules
Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancer.
Impact
Gordon et al., Baltimore, United States. In J Clin Oncol, 2011
and cytokeratin 19 fragment antigen 21-1 (P = .01)
Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.
Impact
Mavroudis et al., Irákleion, Greece. In J Clin Oncol, 2009
PURPOSE: To evaluate the prognostic significance of cytokeratin-19 (CK-19) mRNA-positive circulating tumor cells (CTCs) in peripheral blood of women with early-stage breast cancer after the completion of adjuvant chemotherapy.
Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer.
Impact
Giuliano et al., Pittsburgh, United States. In J Clin Oncol, 2008
METHODS: A beta trial (n = 304) to determine the threshold levels of mammaglobin and cytokeratin 19 correlating with metastasis greater than 0.2 mm and a validation trial (n = 416) to validate the threshold cutoffs were conducted.
More papers using cytokeratin 19 antibodies
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo
Supplier
Borthwick Lee A. et al., In The American Journal of Pathology, 2004
... E-cadherin (610181; Becton, Dickinson and Company, Oxford, UK), fibronectin (F3648; Sigma-Aldrich, Poole, UK), cytokeratin-19 (sc-6278; Santa Cruz Biotechnology, Inc., Santa Cruz, CA), ...
Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy
Supplier
Alzohaili Opada et al., In Diagnostic Pathology, 2004
... CK19RCK1081:100HIER EDTA BufferDako Corp ...
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
Supplier
Saitoh M et al., In Oncogene, 2003
... Rabbit monoclonal anti-keratin 19 and polyclonal δEF1 antibodies were purchased from Epitomics (Burlingame, CA, USA) and ...
Connective tissue growth factor and renal diseases: some answers, more questions
Supplier
Zhang Zhi et al., In Respiratory Research, 2003
... splice form (Fn-EDA) and anti-human cytokeratin-19 were purchased from Abcam Ltd (Cambridge, UK) ...
Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes
Supplier
Mukhopadhyay Asok et al., In The Indian Journal of Medical Research, 2002
... anti-megalin (a kind gift of Mr Dan Biemesderfer, Yale University, USA), anti-E-cadherin (Abcam plc., UK), anti-CK-19 (Santa Cruz Biotechnology Inc., USA), and mouse ...
Cancer genetics
Supplier
Strauss Brian L et al., In Breast Cancer Research, 2000
... AE1/AE3 (clones AE1/AE3; Chemicon, Temecula, CA, USA), to cytokeratin 8 (clone TS1; Vector Laboratories), and to cytokeratin 19 (clone b170; Vector Laboratories) in order to assess ...
Histochemical heterogeneity of human mast cells: disease-related differences in mast cell subsets recovered by bronchoalveolar lavage
Supplier
Onitsuka Toshio et al., In World Journal of Surgical Oncology, 1989
... The specific monoclonal antibody against cytokeratin 19 (Santa Cruz Biotechnology, California, U.S.A.) was used ...
Glutahione replenishment capacity is lower in isolated perivenous than in periportal hepatocytes
Supplier
Afford Simon C. et al., In Febs Letters, 1987
... serum (Sigma) before the addition of mouse anti-human mAb (IgG Isotype-matched control (Invitrogen) CD31 (Dako), cytokeratin 19 (Dako), cytokeratin 18 (Invitrogen) for ...
share on facebooktweetadd +1mail to friends